Cerekinon tablets 100 mg for chronic gastritis and irritable bowel syndrome (trimebutine maleate, Debridat, Recutin, Polybutin)

General information on Japanese Cerekinon tablets 100 mg for chronic gastritis and irritable bowel syndrome (trimebutine maleate, Debridat, Recutin, Polybutin)

Package details: 20 tablets

Manufacturer: Mitsubishi Tanabe Pharma Corporation, Japan

Active ingredient: trimebutine maleate (chemical formula C26H33NO9)

Medical effect: Cerekinon tablets are effective for the treatment of chronic gastritis and irritable bowel syndrome.

Contraindications and precautions: do not use for pregnant or breastfeeding women.

If an allergic reaction occurs, stop taking the medicine and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.

Dosage and administration of Cerekinon tablets 100 mg from Japan for chronic gastritis and irritable bowel syndrome (trimebutine maleate)

For gastrointestinal symptoms caused by chronic gastritis: for adults, take 1 tablet 3 times a day. The dosage may be adjusted according to the age or symptoms by the consulting doctor.

For irritable bowel syndrome: for adults, take 1-2 tablets 3 times a day. The dosage may be adjusted according to the age or symptoms by the consulting doctor.

How effective are Cerekinon tablets 100 mg from Japan for chronic gastritis and irritable bowel syndrome (trimebutine maleate)?

Cerekinon tablets contain 100 mg of trimebutine maleate, a maleic acid salt of trimebutine, a spasmolytic agent. It works by acting on gastrointestinal smooth muscle, suppressing hypermotility and promoting hypomotility of the gastrointestinal tract. Also, Cerekinon tablets relieve abdominal pain and help to restore normal bowel function.

Who should take Cerekinon tablets 100 mg from Japan?

Cerekinon tablets are effective for the treatment of the following diseases and conditions:

1. abdominal enlarged feeling,
2. abdominal pain, nausea and belching caused by chronic gastritis,
3. other gastrointestinal symptoms caused by chronic gastritis,
4. irritable bowel syndrome.

Also, recent clinical studies showed that trimebutine maleate is a potent drug for the treatment of the functional dyspepsia (J. Kountouras, E. Gavalas et al. “Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial”. Medicina (Kaunas). 2020, July, 56(7): 339).